Literature DB >> 33200963

"Profoundly Saddened" Lysogene Discloses Child's Death in Phase II/III Trial.

Alex Philippidis1.   

Abstract

Entities:  

Year:  2020        PMID： 33200963     DOI： 10.1089/hum.2020.29139.bfs

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  2 in total

Review 1.  A versatile toolkit for overcoming AAV immunity.

Authors:  Xuefeng Li; Xiaoli Wei; Jinduan Lin; Li Ou
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

Review 2.  Regulatory Framework for Academic Investigator-Sponsored Investigational New Drug Development of Cell and Gene Therapies in the USA.

Authors:  Anindya Dasgupta; Kristen Herzegh; H Trent Spencer; Christopher Doering; Eric Day; William P Swaney
Journal:  Curr Stem Cell Rep       Date:  2021-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.